Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic Acid
2. Ansaid
3. Apo Flurbiprofen
4. Apo-flurbiprofen
5. Bts 18322
6. Bts-18322
7. Bts18322
8. Cebutid
9. Dobrofen
10. E 7869
11. E-7869
12. E7869
13. Flubiprofen
14. Flugalin
15. Flurbiprofen
16. Fluriproben
17. Froben
18. Froben Sr
19. Neo Artrol
20. Novo Flurprofen
21. Novo-flurprofen
22. Nu Flurbiprofen
23. Nu-flurbiprofen
24. Ocufen
25. Ocuflur
26. Ratio Flurbiprofen
27. Ratio-flurbiprofen
28. Strefen
1. 56767-76-1
2. Sodium Flurbiprofen
3. Ocufen
4. Sodium;2-(3-fluoro-4-phenylphenyl)propanoate
5. Flurbiprofen Sodium?
6. M3qe6as001
7. Flurbiprofen Sodium [usp]
8. Flurbiprofen Sodium Salt
9. Flurbiprofen Sodium Anhydrous
10. Einecs 260-373-2
11. Sodium 3-fluoro-4-phenylhydratropate
12. Unii-m3qe6as001
13. 2-fluoro-alpha-methyl-4-diphenylacetic Acid Sodium Salt
14. Sodium 2-fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetate
15. Sodium 2-(2-fluorobiphenyl-4-yl)propanoate
16. Schembl4735171
17. Chembl1200990
18. Dtxsid80972216
19. (1,1'-biphenyl)-4-acetic Acid, 2-fluoro-alpha-methyl-, Sodium Salt
20. Flurbiprofen Sodium [who-dd]
21. Db-072190
22. (+/-)-flurbiprofen Sodium Anhydrous
23. Flurbiprofen Sodium Anhydrous, (+/-)-
24. Q27283443
25. Sodium2-(2-fluoro-[1,1'-biphenyl]-4-yl)propanoate
26. 2-(2-fluorobiphenyl-4-yl)propionic Acid Sodium Salt
27. 2-fluoro-.alpha.-methyl-4-diphenylacetic Acid Sodium Salt
28. (1,1'-biphenyl)-4-acetic Acid, 2-fluoro-.alpha.-methyl-, Sodium Salt (1:1)
Molecular Weight | 266.24 g/mol |
---|---|
Molecular Formula | C15H12FNaO2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Exact Mass | 266.07190207 g/mol |
Monoisotopic Mass | 266.07190207 g/mol |
Topological Polar Surface Area | 40.1 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 292 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Flurbiprofen sodium |
Drug Label | OCUFEN (flurbiprofen sodium ophthalmic solution, USP) 0.03% is a sterile topical nonsteroidal anti-inflammatory product for ophthalmic use. Chemical Name:Sodium ()-2-(2-fluoro-4-biphenylyl) propionate dihydrate. Structural Formula:C15H12FNaO22... |
Active Ingredient | Flurbiprofen sodium |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 0.03% |
Market Status | Prescription |
Company | Bausch And Lomb |
2 of 4 | |
---|---|
Drug Name | Ocufen |
PubMed Health | Flurbiprofen |
Drug Classes | Analgesic, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, NSAID, Ophthalmologic Agent, Propionic Acid |
Drug Label | OCUFEN (flurbiprofen sodium ophthalmic solution, USP) 0.03% is a sterile topical nonsteroidal anti-inflammatory product for ophthalmic use. Chemical Name:Sodium ()-2-(2-fluoro-4-biphenylyl) propionate dihydrate. Structural Formula:C15H12FNaO22... |
Active Ingredient | Flurbiprofen sodium |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 0.03% |
Market Status | Prescription |
Company | Allergan |
3 of 4 | |
---|---|
Drug Name | Flurbiprofen sodium |
Drug Label | OCUFEN (flurbiprofen sodium ophthalmic solution, USP) 0.03% is a sterile topical nonsteroidal anti-inflammatory product for ophthalmic use. Chemical Name:Sodium ()-2-(2-fluoro-4-biphenylyl) propionate dihydrate. Structural Formula:C15H12FNaO22... |
Active Ingredient | Flurbiprofen sodium |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 0.03% |
Market Status | Prescription |
Company | Bausch And Lomb |
4 of 4 | |
---|---|
Drug Name | Ocufen |
PubMed Health | Flurbiprofen |
Drug Classes | Analgesic, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, NSAID, Ophthalmologic Agent, Propionic Acid |
Drug Label | OCUFEN (flurbiprofen sodium ophthalmic solution, USP) 0.03% is a sterile topical nonsteroidal anti-inflammatory product for ophthalmic use. Chemical Name:Sodium ()-2-(2-fluoro-4-biphenylyl) propionate dihydrate. Structural Formula:C15H12FNaO22... |
Active Ingredient | Flurbiprofen sodium |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 0.03% |
Market Status | Prescription |
Company | Allergan |
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39700
Submission : 2024-05-13
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10248
Submission : 1993-05-17
Status : Inactive
Type : II
Date of Issue : 2022-06-18
Valid Till : 2025-07-07
Written Confirmation Number : WC-0055n
Address of the Firm :
Registrant Name : BASH HEALTH KOREA CORP.
Registration Date : 2022-10-31
Registration Number : 20221031-209-J-1395
Manufacturer Name : Pharmaron Manufacturing Services (UK) LTD
Manufacturer Address : Windmill Industrial Estate Shotton Lane Cramlington Northumberland Ne23 3JL United Kingdom
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
51
PharmaCompass offers a list of Flurbiprofen Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Flurbiprofen Sodium manufacturer or Flurbiprofen Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flurbiprofen Sodium manufacturer or Flurbiprofen Sodium supplier.
PharmaCompass also assists you with knowing the Flurbiprofen Sodium API Price utilized in the formulation of products. Flurbiprofen Sodium API Price is not always fixed or binding as the Flurbiprofen Sodium Price is obtained through a variety of data sources. The Flurbiprofen Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate, including repackagers and relabelers. The FDA regulates Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate supplier is an individual or a company that provides Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate active pharmaceutical ingredient (API) or Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate finished formulations upon request. The Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate suppliers may include Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate active pharmaceutical ingredient (API) in detail. Different forms of Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate DMFs exist exist since differing nations have different regulations, such as Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate USDMF includes data on Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate Drug Master File in Korea (Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate. The MFDS reviews the Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate KDMF as part of the drug registration process and uses the information provided in the Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate suppliers with KDMF on PharmaCompass.
A Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate written confirmation (Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate WC) is an official document issued by a regulatory agency to a Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate manufacturer, verifying that the manufacturing facility of a Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate APIs or Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate finished pharmaceutical products to another nation, regulatory agencies frequently require a Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate WC (written confirmation) as part of the regulatory process.
click here to find a list of Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate suppliers with Written Confirmation (WC) on PharmaCompass.
Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate GMP manufacturer or Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate GMP API supplier for your needs.
A Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate CoA (Certificate of Analysis) is a formal document that attests to Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate's compliance with Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate specifications and serves as a tool for batch-level quality control.
Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate EP), Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate USP).